Clinical trial
Adaptive Radiation Treatment for Head and Neck Cancer (ARTFORCE)
This Phase II trial aims to explore the impact of pre-treatment information and radiation dose redistribution on locoregional control in patients with locally advanced SCCHN.
| Category | Value |
|---|---|
| Study start date | 2011-12-15 |